To pinpoint the next potential multi-bagger, investors should focus on several pivotal trends. A significant indicator to watch is a consistent increase in the return on capital employed (ROCE), coupled with a growing base of capital deployed. This combination typically signifies a company boasting a robust business model alongside numerous avenues for lucrative reinvestment. Therefore, upon our preliminary assessment of Shanghai GenTech‘s (SHSE:688596) ROCE trajectory, we felt a wave of optimism at its promising indicators.
Return On Capital Employed (ROCE): What Is It?
For those unfamiliar, ROCE serves as a critical measurement of a company’s annual pre-tax profit, representing its return relative to the total capital utilized in the business framework. To calculate this for Shanghai GenTech, investors can use the following formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)
0.12 = CN¥481m ÷ (CN¥9.3b – CN¥5.2b) (Based on the trailing twelve months to September 2024).
Shanghai GenTech boasts an ROCE of 12%. While this figure is satisfactory on its own, it outshines the Semiconductor industry average, which stands at a meager 4.8%.
For a deeper look, check out our latest analysis for Shanghai GenTech.
SHSE:688596 Return on Capital Employed November 25th 2024
While observed current ROCE for Shanghai GenTech reflects positively against prior returns, it’s essential to recognize that historical data offers limited foresight. For those keen to understand future projections, we highly recommend exploring our complimentary analyst report on Shanghai GenTech.
What The Trend Of ROCE Can Tell Us
Despite the fact that current returns on capital are relatively steady, they have not undergone substantial variation. Over the past five years, the company has seen a remarkable 464% increase in capital employed, with returns remaining stable at 12%. This rate of return is viewed as standard; however, the reliability of Shanghai GenTech’s consistent earnings provides a certain level of assurance. While stable returns may lack excitement, their sustainability over time can yield significant rewards for shareholders.
The Bottom Line On Shanghai GenTech’s ROCE
Ultimately, Shanghai GenTech has demonstrated a commendable capacity to reinvest capital diligently, achieving impressive rates of return. Consequently, it comes as no surprise that shareholders who have remained invested over the last three years have realized a notable 30% return. Although the stock might appear somewhat “expensive” in comparison to prior prices, we believe that the strong fundamental indicators justify further exploration into this stock.
Additionally, it is important to mention that we have pinpointed 4 warning signs associated with Shanghai GenTech, with at least one raising a valid concern. Gaining an understanding of these factors could prove beneficial for potential investors.
For those on the lookout for solid companies, we invite you to review this free list showcasing businesses with robust balance sheets and impressive returns on equity.
New: Manage All Your Stock Portfolios in One Place
We have developed the ultimate portfolio companion tailored for stock investors, and it’s completely free.
• Connect an unlimited number of Portfolios and consolidate your totals in a single currency
• Receive alerts for new warning signs or risks via email or mobile notifications
• Monitor the fair value of your holdings
Discover the benefits by trying a Demo Portfolio for Free.
How does Shanghai GenTech’s ROCE compare to its competitors in the semiconductor industry, and what does this indicate about its operational efficiency?
**Interview with Financial Analyst Karen Lee on Shanghai GenTech’s ROCE Trends**
**Interviewer:** Thank you, Karen, for joining us today to discuss Shanghai GenTech’s financial performance, particularly its Return on Capital Employed (ROCE). Can you explain to our viewers why ROCE is such an important metric for investors?
**Karen Lee:** Absolutely! ROCE is a key indicator of how efficiently a company is using its capital to generate profits. It measures the return generated on every unit of capital employed. A strong ROCE suggests that the company not only has a solid business model but also potential for further investment and growth. Investors often look for companies that can sustain or increase their ROCE over time as it indicates good management and operational efficiency.
**Interviewer:** I read that Shanghai GenTech currently has a ROCE of 12%. How does this compare to industry standards?
**Karen Lee:** Yes, Shanghai GenTech’s ROCE of 12% is quite impressive, especially when you consider that the average for the semiconductor industry is only about 4.8%. This disparity suggests that Shanghai GenTech is not only performing well but also has a competitive edge in effectively deploying its capital.
**Interviewer:** Interesting! You mentioned that there has been a significant increase in the capital employed by Shanghai GenTech, which rose by 464% over the past five years. How does this play into their overall financial health?
**Karen Lee:** The increase in capital employed is a strong positive signal. It indicates that Shanghai GenTech is actively investing in its operations, whether that be through expanding capabilities, enhancing production, or developing new products. The fact that ROCE has remained stable at 12% during this capital expansion suggests that the company is maintaining its profitability while effectively utilizing this increased capital. This stability amidst rapid growth is reassuring for investors.
**Interviewer:** Given these optimistic indicators, what should investors be cautious about?
**Karen Lee:** While the current ROCE is promising, it’s crucial for investors to look at the broader context. Historical data is a valuable guide, but it doesn’t always predict future performance. Investors should consider market conditions, competitive pressures, and any potential shifts in technology that could impact the semiconductor sector. Additionally, keeping an eye on how the company continues to manage its capital and whether they can uphold this ROCE is vital.
**Interviewer:** Thanks for those insights, Karen. For investors looking at Shanghai GenTech as a potential multi-bagger, what final thoughts would you share?
**Karen Lee:** I would advise investors to look deeper into Shanghai GenTech’s overall strategy and future growth prospects. If they continue to successfully reinvest their earnings while maintaining a healthy ROCE, this could indeed make them a strong candidate for significant growth. It’s always wise for investors to stay informed through comprehensive analysis and reports to make well-informed decisions.
**Interviewer:** Thank you, Karen, for your valuable insights on Shanghai GenTech and ROCE. It’s been a pleasure discussing this with you!
**Karen Lee:** Thank you for having me! Always a pleasure to share insights on such an important investment topic.
